Liposuction for Chronic Lipoedema (IPG721)
Published 29th March 2022
NICE (National Institute for Health and Care Excellence) acknowledges that lipoedema is distinct from obesity and lymphoedema.
NICE recognises that lipoedema is common, under-recognised and extremely debilitating and considerably more prevalent in women than men.
NICE recommends that there needs to be more research to understand who would benefit most from liposuction, long term outcomes and Quality of Life (QOL).
NICE will review their guidance upon publication of future trials and research.
Link to full NICE report:
NICE (National Institute for Health and Care Excellence) acknowledges that lipoedema is distinct from obesity and lymphoedema.